We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Symptomatic Efficacy of Diacerein in Knee Osteoarthritis

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00445276
First Posted: March 8, 2007
Last Update Posted: March 4, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Laboratoires NEGMA
  Purpose
Pain is the main symptom of osteoarthritis that motivates medical visits. Diacerhein has already demonstrated its efficacy in knee and/or hip osteoarthritis. This study aims at confirming the efficacy of diacerhein in symptomatic knee osteoarthritis using known and validated criteria and according to the recommendations and guidelines for this kind of study.

Condition Intervention Phase
Knee Osteoarthritis Drug: Diacerein Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Treatment
Official Title: Efficacy Study of Diacerein in the Symptomatic Treatment of Knee Osteoarthritis

Resource links provided by NLM:


Further study details as provided by Laboratoires NEGMA:

Primary Outcome Measures:
  • VAS on pain movement, WOMAC A 1.1 section

Secondary Outcome Measures:
  • WOMAC : total, pain, physical function
  • Paracetamol consumption
  • Global assessment of the patient
  • Responder patients with OMERACT-OARSI criteria
  • Tolerance

Estimated Enrollment: 500
Study Start Date: November 2005
Study Completion Date: September 2006
Primary Completion Date: September 2006 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Painful primary osteoarthritis (VAS ≥ 40 mm)
  • Radiologically proven (Kellgren & Lawrence grade I to III)
  • Requiring the prescription of a symptomatic treatment of pain

Exclusion Criteria:

  • Severe associated diseases
  • Wash-out: AINS, Coxibs, Paracetamol, anti-osteoarthritic treatments, hyaluronic acid, knee tidal lavage
  • Other osteoarticular disease
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00445276


Locations
France
Chu Trousseau
Tours, France, 37044
Sponsors and Collaborators
Laboratoires NEGMA
Investigators
Principal Investigator: Jean - Pierre Valat Unafilliated
  More Information

Responsible Party: Patrick Darses, Negam-Lerads
ClinicalTrials.gov Identifier: NCT00445276     History of Changes
Other Study ID Numbers: HEC / ART 05 566 N
AFSSAPS:050984
CCPPRB:2005-27
First Submitted: March 6, 2007
First Posted: March 8, 2007
Last Update Posted: March 4, 2010
Last Verified: March 2010

Keywords provided by Laboratoires NEGMA:
Osteoarthritis
Knee
Diacerein
Painful osteoarthritis
Clinical trial

Additional relevant MeSH terms:
Osteoarthritis
Osteoarthritis, Knee
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Diacetylrhein
Anti-Inflammatory Agents